SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 99 filers reported holding SILVERBACK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,026,685 | -31.0% | 536,160 | +22.3% | 0.00% | – |
| Q2 2023 | $2,938,292 | +249.4% | 438,551 | +239.5% | 0.00% | – |
| Q1 2023 | $841,033 | -42.6% | 129,191 | -24.8% | 0.00% | – |
| Q4 2022 | $1,465,300 | +310.4% | 171,782 | +154.1% | 0.00% | – |
| Q3 2022 | $357,000 | +24.4% | 67,591 | 0.0% | 0.00% | – |
| Q2 2022 | $287,000 | -76.2% | 67,591 | -80.4% | 0.00% | – |
| Q1 2022 | $1,208,000 | -44.0% | 344,194 | +6.2% | 0.00% | – |
| Q4 2021 | $2,158,000 | -29.1% | 324,013 | +6.2% | 0.00% | – |
| Q3 2021 | $3,045,000 | -56.1% | 305,069 | +36.0% | 0.00% | – |
| Q2 2021 | $6,929,000 | -17.4% | 224,319 | +16.7% | 0.00% | – |
| Q1 2021 | $8,384,000 | – | 192,164 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,618,036 | $80,871,000 | 3.02% |
| Orbimed Advisors | 8,740,887 | $270,006,000 | 2.73% |
| Boxer Capital, LLC | 1,675,377 | $51,752,000 | 1.83% |
| Endurant Capital Management LP | 139,124 | $4,298,000 | 1.18% |
| Nantahala Capital Management | 1,266,266 | $39,115,000 | 1.11% |
| COMMODORE CAPITAL LP | 97,143 | $3,001,000 | 1.05% |
| Ally Bridge Group (NY) LLC | 128,572 | $3,972,000 | 0.99% |
| RA Capital Management | 1,742,186 | $53,816,000 | 0.86% |
| HighVista Strategies LLC | 25,906 | $800,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 173,891 | $5,371,000 | 0.36% |